JAGGAER, the global leader in Autonomous Commerce, is collaborating with CiteAb, a UK-based provider of high-quality life science data, to enable researchers to identify, select and procure the right biological reagents for their work. The integrated solution will offer efficiency gains, cost savings and compliance improvements via JAGGAER Research Material Management (RMM), the industry-leading solution for acquiring and managing commercial reagents and lab supplies used in research.
“The partnership with CiteAb is another example of JAGGAER working to extend the breadth and depth of our comprehensive solution footprint to meet very specific vertical sector needs”
The integration of CiteAb data within JAGGAER RMM will be available in June 2022 to new and existing JAGGAER RMM customers.
“JAGGAER RMM has long been the solution of choice for lab researchers looking for chemical reagents. We are delighted that CiteAb’s expertise in biological reagent search will be available to researchers who use JAGGAER’s purchasing systems,” said Dr. Andrew Chalmers, CEO of CiteAb.
Also Read: Splunk Appoints Petra Jenner as Senior Vice President
“By searching for and identifying products on CiteAb to purchase from preferred suppliers on JAGGAER RMM, life sciences and higher education institutions will reduce the risk of buying the wrong reagents. Moreover, based on what RMM clients already save on chemical materials and lab supplies, they now stand to save an average of 20% on biological reagents, year after year,” Dr. Chalmers added. “That’s a great plus for life scientists, some of whom spend millions of dollars per year on antibodies alone.”
Researchers typically begin their purchase process with an exploratory search, but biologists, like chemists, often do not know the exact reagents they need to acquire. For chemists, RMM offers chemical structure search, cross-referencing results with available inventory and catalog items, and actual contract pricing and availability, to simplify and optimize selection.
A search for a known antibody is likely to return 1,000 or more product results. Unlike pure compounds, these results are fundamentally different in critical dimensions, including clonality, reactivity, the application for which they are intended, and the host species from which they are derived. Using the wrong reagent wastes money, slows research progress, and can damage the credibility of research programs.
Dr. Chalmers, working with a team that came together at the University of Bath, England, pioneered CiteAb’s search engine to address this challenge. CiteAb fundamentally changes the way researchers find reagents for their experiments by combining advanced text mining, the classification of published research literature, actual supplier product catalog content, published image collection and extensive human curation by CiteAb experts. The result is higher data accuracy and reliability.
“The partnership with CiteAb is another example of JAGGAER working to extend the breadth and depth of our comprehensive solution footprint to meet very specific vertical sector needs,” commented Jim Bureau, CEO, JAGGAER.
“CiteAb provides researchers streamlined discovery and simplified buying, and suppliers centralized access to a large network of buyers,” said Tom Russell, General Manager, RMM Solutions. “Those benefits epitomize autonomous commerce.”